Related Experiment Video

Updated: Jun 3, 2025

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.1K

Advantages of Broad-Spectrum Influenza mRNA Vaccines and Their Impact on Pulmonary Influenza

Ziqi Cheng1,2, Junfeng Ma1, Chenyan Zhao2

  • 1National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China.

Vaccines
|January 8, 2025
PubMed

Insights

Messenger RNA (mRNA) vaccines offer a promising solution for influenza prevention. This technology enables rapid development and broad protection against rapidly mutating influenza viruses, improving upon traditional vaccines.

Area of Science:

  • Virology
  • Vaccinology
  • Biotechnology

Background:

  • Influenza viruses exhibit rapid mutation and antigenic variability, leading to seasonal epidemics and frequent outbreaks.
  • Traditional influenza vaccines face challenges in providing comprehensive protection due to strain mismatches.
  • A broad-spectrum vaccine is essential for effective global influenza management.

Purpose of the Study:

  • To explore the potential of messenger RNA (mRNA) vaccine technology for influenza prevention.
  • To highlight the advantages of mRNA vaccines in addressing the challenges posed by influenza's antigenic variability.
  • To present mRNA vaccines as a revolutionary approach for adaptable and broad protection against evolving influenza strains.

Main Methods:

  • Review of influenza virus antigenic variation mechanisms.
  • Analysis of mRNA vaccine design, production speed, and adaptability.
  • Comparison of mRNA vaccine immunogenicity, antigen encoding capacity, safety, and stability with traditional vaccines.

Main Results:

  • mRNA vaccines allow for rapid design and production in response to emerging strains.
  • Encoding of multiple antigens in mRNA vaccines can enhance immunogenicity and broaden protection.
  • mRNA vaccines demonstrate favorable safety and stability profiles compared to conventional methods.

Conclusions:

  • mRNA vaccine technology offers a swift, adaptable, and potentially broad protective response against influenza.
  • Leveraging mRNA technology can significantly improve global influenza management and response strategies.
  • mRNA vaccines represent a revolutionary advancement in the prevention of influenza.
Keywords:
broad-spectrum influenza vaccinemRNA Vaccine mRNApulmonary influenza

More Related Videos

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection05:21

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

25.1K
Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

3.2K

Related Concept Videos

Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
Vaccinations01:51

Vaccinations

Overview
44.0K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.2K